Distinctive pattern of glial fibrillary acidic protein immunoreactivity useful in distinguishing fragmented pleomorphic adenoma, canalicular adenoma and polymorphous low grade adenocarcinoma of minor salivary glands

Head and Neck Pathology

Volumn 1, Issue 1, 2007, Pages 27-32

  Curran, Alice E ^a   Allen, Carl M ^b   Beck, F Michael ^b   Damm, Douglas D ^c   Murrah, Valerie A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Canalicular adenoma; Glial fibrillary acidic protein; Immunohistochemistry; Pleomorphic adenoma; Polymorphous low grade adenocarcinoma; Salivary gland neoplasms

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MINOR SALIVA GLAND; PATHOLOGY; PLEOMORPHIC ADENOMA; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MIDDLE AGED; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS, MINOR; TUMOR MARKERS, BIOLOGICAL;

EID: 77957364756     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-007-0003-8     Document Type: Article

References (12)

1. Gnepp DR, el-Mofty S. Polymorphous low grade adenocarcinoma: glial fibrillary acidic protein staining in the differential diagnosis with cellular mixed tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:691-5.
2. Castle JT, Thompson LD, Frommett RA, Wenig BM, Kessler HP. Polymorphous low-grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer 1999;86:207-19.
3. Curran AE, White DK, Damm DD, Murrah VA. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:194-9.
4. Gould VE, Koukoulis GK, Jansson DS, Franke WW, Moll R. Coexpression patterns of vimentin and glial fibrillary acidic protein in normal, hyperplastic and neoplastic breast. Am J Surg Pathol 1990;137:1143-55.
5. Liuder TM, Kros JM, Sillevis Smitt PA, van den Bent MJ, Vecht CJ. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodenroglioma. Electrophoresis 1999;20: 1087-91.
6. Murphy KG, Hatton JD. Role of glial fibrillary acidic protein expression in the biology of human glioblastoma U-373MG cells. J Neurosurg 1998;89:997-1006.
7. Zarbo RJ, Prasad AR, Regezi JA, Gown AM, Savera AT. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med 2000;124:401-5.
8. Sharkey TE. Systematic evaluation of WHO classification of salivary gland tumors: a clinicopathologic study of 366 cases. Am J Clin Pathol 1977;67:272-8.
9. Ellis GL, Auclair PL. Tumors of the salivary glands. Third Series. Washington DC: Armed Forces Institute of Pathology; 1996. 100.
10. Nishimura T, Furukawa M, Kawahara E, Miwa A. Differential diagnosis of pleomorphic adenoma by immunohistochemical means. J Layngol Otol 1991;105:1057-60.
11. Rousseau A, Mock D, Dover DG, Jordan RC. Multiple canalicular adenomas: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87:346-50.
12. Viale G, Gambacorta M, Coggi G, Dell'Orto P, Milani M, Doglioni C. Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast. Virchows Arch A Pathol Anat Histopathol 1991;418:339-8.